Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial
Crossref DOI link: https://doi.org/10.1186/s12967-015-0747-y
Published Online: 2016-01-13
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Leibowitz-Amit, Raya
Pintilie, Melania
Khoja, Leila
Azad, Arun A.
Berger, Raanan
Laird, A. Douglas
Aftab, Dana T.
Chi, Kim N.
Joshua, Anthony M.